Skip to main content

Preet Bharara May Throw JP Morgan A Bone

  • Author:
  • Updated:
    Original:

In this case the bone would be a "deferred prosecution agreement" wherein the bank would get a brief reprieve from dealing with one of the 979 investigations it is currently facing.

JP Morgan under siege on multiple fronts by state and federal prosecutors investigating alleged wrongdoing at the largest U.S. bank, is in talks with the Manhattan U.S. attorney to resolve allegations it helped enable the biggest Ponzi scheme. The probe by Manhattan U.S. Attorney Preet Bharara, tied to how the bank handled the funds of convicted money manager Bernard Madoff and whether it turned a blind eye to his multibillion-dollar fraud, may end in a deferred prosecution agreement, a person familiar with the matter said. Under such an agreement, the government agrees not to pursue prosecution for a limited period of time and dismiss the charges if the entity or individual improves its programs or complies with the law. It is one of several options being discussed by prosecutors and the bank, including resolving the matter with just a fine, said the person, who requested anonymity because the talks are private.

JPMorgan Said to See Possible Accord on Madoff Scheme [Bloomberg]

Related

If You Need Preet Bharara, He'll Be In His Office Screaming Into A Pillow

It's like the Supreme Court is trying to hurt him/discredit his life's work.

preet

Preet Bharara Is Going Out In The Most Preet Bharara Way Possible

Getting fired by the president might be the best thing that ever happened to Preet Bharara.

Preet Bharara: University Of Michigan Doctor Financially Compensated For Leaking Confidential Drug Trial Data To Former SAC Trader Just An Innocent Pawn In Big Bad Hedge Fund's Game

As you may have heard, earlier today, Mathew Martoma, a former portfolio manager in SAC Capital's CR Intrinsic unit, was charged with allegedly running “the most lucrative insider trading scheme ever," netting $276 million for the fund. He did so based on information that was given to him by Sid Gilman, a University of Michigan neurologist and chair of a "safety-monitoring committee that oversaw a clinical trial by Wyeth LLC and Elan Corp.  into whether the drug bapineuzumab, or bapi, was safe for patients with mild-to-moderate Alzheimer’s disease." Over an 18-month period, Gilman and Martoma met 42 times, in addition to emailing and chatting over the phone. For example:

RBS, Barclays In For A World Of Pain: JP Morgan

Any money the banks are making now should apparently be earmarked for future payouts to regulators, of which there will be many.